Adaptin Bio, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Adaptin Bio, Inc. (APTN) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $211.31 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-28
- Adaptin Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$157.87K, a 106.75% decline year-over-year.
- Adaptin Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $2.34M, a 767160.33% increase year-over-year.
- Adaptin Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $305.00.
- Adaptin Bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$120.00.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 10 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $211.31K S-1 · filed 2026-08-28 | |||||||
| 2026-03-31 | -$157.87K POS AM · filed 2026-07-21 | |||||||
| 2025-12-31 | $425.09K S-1 · filed 2026-08-28 | |||||||
| 2025-09-30 | $545.00K 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | $1.32M S-1 · filed 2026-08-28 | |||||||
| 2025-03-31 | $2.34M POS AM · filed 2026-07-21 | |||||||
| 2024-12-31 | $29.33K S-1 · filed 2026-08-28 | $12.24K 10-K · filed 2025-04-15 | ||||||
| 2024-09-30 | $110.55K 10-Q · filed 2025-11-14 | -$58.00 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | $19.02K 10-Q · filed 2025-08-14 | -$58.00 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | $305.00 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | -$120.00 10-K · filed 2025-04-15 | |||||||
| 2023-09-30 | -$120.00 10-Q · filed 2024-11-14 | |||||||
| 2022-12-31 | $500.00 10-K · filed 2024-04-01 |